[

vk paul

]
India has banned the export of remdesivir and its ingredients in an attempt to address the shortage(AFP / File Photo)

Government calls for rational remdesivir application

By HT Correspondent, New Delhi
UPDATED ON APR 14, 2021 02:14 AM IST
  • Remdesivir, an injection, continues to be used in India despite WHO recommending against its use, on the grounds that there is no evidence that it works.
The government has faced questions for what critics termed rushed approvals to the two vaccines, especially Covaxin, which is yet to release its phase III data. Bharat Biotech, however, has said the vaccine is “200% safe”.(ANI)
The government has faced questions for what critics termed rushed approvals to the two vaccines, especially Covaxin, which is yet to release its phase III data. Bharat Biotech, however, has said the vaccine is “200% safe”.(ANI)

Covering all 300 million people could take 7-8 months: VK Paul

Hindustan Times, New Delhi | By Anonna Dutt, New Delhi
UPDATED ON JAN 07, 2021 02:55 AM IST
VK Paul, who was the head of the department of paediatrics at AIIMS, was talking about the logistics of the large-scale vaccination drive India is set to initiate and how the priority groups – healthcare workers, frontline workers, people over 50, and those who have comorbid conditions – were selected for the first phase.
Health experts were asked which vaccines they would lie to take between Covishield and Covaxin. (Photo: PIB)
Health experts were asked which vaccines they would lie to take between Covishield and Covaxin. (Photo: PIB)

‘Will take that vaccine...’: Experts explain why Bharat Biotech’s vaccine got approval

Hindustan Times, New Delhi | By hindustantimes.com | Edited by Poulomi Ghosh
UPDATED ON JAN 05, 2021 09:38 PM IST
Government experts on Tuesday clarified why Covaxin has been given the nod for restricted emergency use.
Rajasthan CM Ashok Gehlot.(HT photo)
Rajasthan CM Ashok Gehlot.(HT photo)

News updates from Hindustan Times: Court seeks Rajasthan govt’s reply on work in jails given on caste lines and all the latest news

Hindustan Times, New Delhi | By hindustantimes.com
UPDATED ON DEC 19, 2020 09:01 PM IST
Here are today’s top news, analysis and opinion. Know all about the latest news and other news updates from Hindustan Times.
The National Expert Group on Vaccine Administration for Covid-19 (NEGVAC), headed by Dr Paul, has recommended that 10 million healthcare staff, 20 million frontline workers and 270 million people over the age of 50 or with co-morbidities be given the vaccines on priority once it becomes available.(AP)
The National Expert Group on Vaccine Administration for Covid-19 (NEGVAC), headed by Dr Paul, has recommended that 10 million healthcare staff, 20 million frontline workers and 270 million people over the age of 50 or with co-morbidities be given the vaccines on priority once it becomes available.(AP)

12 nations reached out to India for Covid vaccine: NITI Aayog’s VK Paul

Hindustan Times, New Delhi | By HT Correspondent
UPDATED ON DEC 19, 2020 07:37 PM IST
Dr Paul informed the GoM about the vaccine candidates in trial in India, the manufacturers, doses to become available and conditions for storage.
The NITI Aayog member also expressed concern over Covid-19 spread amid the ongoing farmers’ protest at the borders of the national capital.(File photo for representation)
The NITI Aayog member also expressed concern over Covid-19 spread amid the ongoing farmers’ protest at the borders of the national capital.(File photo for representation)

Six Covid-19 vaccines currently undergoing clinical trials in India

New Delhi | By Asian News International | Posted by Niyati Singh
UPDATED ON DEC 15, 2020 06:28 PM IST
Informing that the Drugs Controller General of India has granted clearance for the clinical trials of one more candidate vaccine from India, NITI Aayog Member (Health) Dr VK Paul on Tuesday said six vaccines are currently undergoing clinical trials in the country.
A man walks past a graffiti amid the spread of the coronavirus disease (Covid-19) in Mumbai, India, November 2, 2020.(Reuters photo)
A man walks past a graffiti amid the spread of the coronavirus disease (Covid-19) in Mumbai, India, November 2, 2020.(Reuters photo)

No unusual national Covid-19 surge in 1st phase of festivals: VK Paul

Hindustan Times, New Delhi | By Rhythma Kaul
UPDATED ON NOV 05, 2020 05:36 AM IST
There has been no unusual surge in Covid-19 cases over the past couple of weeks, contrary to what was feared before the start of the festive season, says Dr VK Paul, member (health) Niti Aayog, while warning that there’s still a week before the actual impact could be felt.
Health workers in PPE coveralls at work during sample collection for coronavirus testing at Hari Nagar in New Delhi on Saturday.(Sanchit Khanna/HT Photo)
Health workers in PPE coveralls at work during sample collection for coronavirus testing at Hari Nagar in New Delhi on Saturday.(Sanchit Khanna/HT Photo)

Delhi plans infra for up to 12,000 Covid-19 cases in a day

Hindustan Times, New Delhi | By Sweta Goswami
UPDATED ON NOV 01, 2020 05:02 AM IST
Amid the worrying surge in cases in Delhi and the onset of the winter season, the Union home ministry has called a special review meeting with Delhi government officials on Monday to check the spiralling of infections.
Delhi health minister and AAP leader Satyendar Kumar Jain during a press conference in New Delhi.(PTI File Photo)
Delhi health minister and AAP leader Satyendar Kumar Jain during a press conference in New Delhi.(PTI File Photo)

Health minister Jain puts spike on better tracing, but numbers don’t really add up

Hindustan Times, New Delhi | By Sweta Goswami
UPDATED ON OCT 30, 2020 03:49 AM IST
An expert committee headed by NITI Ayog member (health) VK Paul has warned that the number of cases in Delhi could go up to 15,000 a day during the winter months.
A relative wearing Personal Protective Equipment (PPE) near a handcart carrying the body of a person who died from the Covid-19, at Nigambodh Ghat cremation ground, in New Delhi.(Sanjeev Verma/HT PHOTO)
A relative wearing Personal Protective Equipment (PPE) near a handcart carrying the body of a person who died from the Covid-19, at Nigambodh Ghat cremation ground, in New Delhi.(Sanjeev Verma/HT PHOTO)

Prioritisation has to be done on criteria for Covid-19 vaccination, says Dr VK Paul

New Delhi, Delhi | By Asian News International | Posted by Shivani Kumar
UPDATED ON OCT 27, 2020 11:04 PM IST
Dr Paul also said that discussions in the committee of Union Government are being conducted and blueprints are being finalized and added that committee and oversee that in order to deliver the vaccine to priority groups, there will be no problems in terms of resources.
Photo provided by the Russian Direct Investment Fund (RDIF) shows samples of a vaccine against the coronavirus disease (Covid-19) developed by the Gamaleya Research Institute of Epidemiology and Microbiology in Moscow.(Reuters File Photo)
Photo provided by the Russian Direct Investment Fund (RDIF) shows samples of a vaccine against the coronavirus disease (Covid-19) developed by the Gamaleya Research Institute of Epidemiology and Microbiology in Moscow.(Reuters File Photo)

Results of Covid-19 vaccines’ trial to take a few weeks, says VK Paul

Hindustan Times, New Delhi | By Rhythma Kaul
UPDATED ON AUG 19, 2020 07:49 PM IST
The two Covid-19 vaccine candidates that are in phase I/II human trials are drug maker Zydus Cadila’s ZyCov-D and Bharat Biotech’s Covaxin.
Officials said the interest levels of candidates in the non-clinical subjects is so low that even after the ministry brought down the cut off by 6 percentile points, still many seats went vacant.(HT File)
Officials said the interest levels of candidates in the non-clinical subjects is so low that even after the ministry brought down the cut off by 6 percentile points, still many seats went vacant.(HT File)

Centre, MCI to meet over tepid response to non-clinical subjects

New Delhi | By Rhythma Kaul
PUBLISHED ON MAY 26, 2019 10:06 PM IST
Officials said the interest levels of candidates in the non-clinical subjects is so low that even after the ministry brought down the cut off by 6 percentile points, still many seats went vacant.
Government may ease medical college norms(HT File Photo)
Government may ease medical college norms(HT File Photo)

Government likely to ease medical college norms

New Delhi | By Rhythma Kaul
UPDATED ON FEB 24, 2019 10:42 AM IST
Under the Indian Medical Council (MCI) Act, 1956, licences to run a medical college or add seats are denied when institutions do not meet the minimal requirements for infrastructure, faculty and clinical work, among others.
A month after the launch of Centre’s Ayushman Bharat health insurance scheme, about 6, 340 government hospitals are providing treatment as they are empanelled by default.(Yogendra Kumar/HT PHOTO)
A month after the launch of Centre’s Ayushman Bharat health insurance scheme, about 6, 340 government hospitals are providing treatment as they are empanelled by default.(Yogendra Kumar/HT PHOTO)

A month on, Modi government’s Ayushman Bharat health plan needs more hospitals

Hindustan Times, New Delhi | By Rhythma Kaul
UPDATED ON NOV 02, 2018 04:02 PM IST
The lack of adequate number of hospitals empanelled under AB-PMJAY is clearly apparent with just about 7,789 private hospitals treating patients under the scheme. The private hospitals are in the process of getting empanelled. So far, about 6, 340 government hospitals are providing treatment as they are empanelled by default.
SHARE
Story Saved